Q32 Bio: Bempikibart Keeps The Alopecia Areata Bull Case Alive [Seeking Alpha]
Q32 Bio Inc. (QTTB)
Company Research
Source: Seeking Alpha
Management sold ADX-097 to Akebia, which brings milestone and royalty payments as an extra while concentrating its efforts on Bempikibart's R&D. Bempikibart's prior data and ongoing OLE data suggest durable responses and possible remission. This keeps my long-term alopecia areata thesis alive for QTTB. While I reckon cash burn, dilution, and timeline risks remain, I ultimately feel QTTB could become a long-term winner on AA for patient investors. VLG/iStock via Getty Images Q32 Bio Inc. ( QTTB ) is a clinical-stage biotech that develops Bempikibart, which is a candidate for treating alopecia areata (AA). This drug is in Phase 2a of the SIGNAL-AA trial and has reported positive data from previous studies. Bempikibart
Show less
Read more
Impact Snapshot
Event Time:
QTTB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QTTB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QTTB alerts
High impacting Q32 Bio Inc. news events
Weekly update
A roundup of the hottest topics
QTTB
News
- Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare ConferencePR Newswire
- Q32 Bio (QTTB) Upgraded to Strong Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- Q32 Bio (QTTB) was upgraded by Zacks Research from "hold" to "strong-buy".MarketBeat
- Wall Street Analysts See a 103.55% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High? [Yahoo! Finance]Yahoo! Finance
QTTB
Sec Filings
- 3/27/26 - Form 8-K
- 3/27/26 - Form 424B5
- 3/20/26 - Form 4
- QTTB's page on the SEC website